Could a common diabetes pill save transplanted kidneys?
NCT ID NCT07555106
First seen May 07, 2026 · Last updated May 19, 2026 · Updated 3 times
Summary
This study tests whether dapagliflozin, a drug used for diabetes, can help protect kidney function in people who received a kidney transplant from a living donor. About 54 adults will take the drug daily or receive standard care. Researchers will measure kidney function, scarring, and rejection over 12 months to see if the drug improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Universidad de Guadalajara
Guadalajara, Jalisco, 44250, Mexico
Conditions
Explore the condition pages connected to this study.